The latest update of “Global Breast Cancer Diagnostics Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Breast Cancer Diagnostics Market.
Overview of the Breast Cancer Diagnostics Market:
It is estimated that in the United States, in 2021, an estimated 281,550 new cases of invasive breast cancer are expected to be diagnosed in women, along with 49,290 new cases of non-invasive (in situ) breast cancer. This makes it the most common cancer among women. Breast cancer is often first noticed during a mammogram. Other causes of this type of abnormal cell are the accumulation of fluid in the breast ducts, the spread of cancer cells into the lymph nodes, or the presence of a tumor that is pressing against the breast duct. Although some cancers may not produce any symptoms, most cases of breast cancer will involve some indication of a change in the shape or size of the breast, bleeding or discomfort in the area of the breast, or pain or sensitivity in the area of the breast.
Market Dynamics
Increasing adoption of AI-based diagnostics is expected to propel the growth of the global breast cancer diagnostics market over the forecast period. For instance, in July 2019, SimonMed Imaging, an outpatient medical imaging provider, implemented ProFound AI for digital breast tomosynthesis (DBT), the first FDA-cleared AI program for early breast cancer detection developed by iCAD, Inc.
Development and approval of AI-based diagnostics is expected to offer lucrative growth opportunities for players in the global breast cancer diagnostics market. For instance, in March 2020, ScreenPoint Medical received the US Food and Drug Administration’s approval for Transpara 1.6.0, the first breast AI solution for both 2D and 3D mammography in the U.S. Moreover, increasing adoption of WATS3D biopsy is also expected to aid in the growth of the market. For instance, in April 2020, CDx Diagnostics, Inc. announced that the company is contracted with Blue Cross Blue Shield (BCBS) of Massachusetts for WATS3D Biopsy (Wide Area Transepithelial Sampling with 3D Tissue Analysis).
Key Takeaways
- Increasing prevalence of breast cancer is expected to propel the growth of the global breast cancer diagnostics market over the forecast period. For instance, according to the American Cancer Society, in 2020, around 276,480 new cases of invasive breast cancer will be diagnosed in women and the disease will lead to around 42,170 deaths, in the U.S.
- Major players operating in the global breast cancer diagnostics market are focused on adopting partnership strategies for R&D purposes. For instance, in September 2021, Genetic Technologies partnered with Washington University's Institute for Public Health on a study designed to expand the predictive capability of the company's GeneType breast cancer risk assessment test for women of African descent.
- Major players operating in the global breast cancer diagnostics market include Hologic Inc., Danaher Corporation, Qiangen N.V., Koninklijke Philips N.V., F. Hoffmann-La Roche Limited, Argon Medical Devices Inc., and BD
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Breast Cancer Diagnostics Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Breast Cancer Diagnostics Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Hologic Inc.
- Danaher Corporation
- QIANGEN N.V.
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Limited
- Argon Medical Devices
- Inc.
- and BD
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Breast Cancer Diagnostics Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Imaging
- Blood Tests
- Genomic Tests
- Biopsy
By Applications, the market is segmented into:
- Platform-based
- Instrument-based
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breast Cancer Diagnostics Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Breast Cancer Diagnostics Market Share by Application: 2021 VS 2027
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Breast Cancer Diagnostics Market
1.6.1 How the Covid-19 is Affecting the Breast Cancer Diagnostics Market
1.6.1.1 Breast Cancer Diagnostics Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Breast Cancer Diagnostics Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Breast Cancer Diagnostics Market Perspective (2015-2027)
2.2 Breast Cancer Diagnostics Market Growth Trends by Regions
2.2.1 Breast Cancer Diagnostics Market Size by Regions: 2015 VS 2021 VS 2027
2.2.2 Breast Cancer Diagnostics Market Historic Market Share by Regions (2015-2021)
2.2.3 Breast Cancer Diagnostics Market Forecasted Market Size by Regions (2021-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Breast Cancer Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Breast Cancer Diagnostics Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Diagnostics Market Players by Market Size
3.1.1 Global Top Breast Cancer Diagnostics Market Players by Revenue (2015-2021)
3.1.2 Global Breast Cancer Diagnostics Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Breast Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breast Cancer Diagnostics Market Concentration Ratio
3.2.1 Global Breast Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostics Market Revenue in 2019
3.3 Breast Cancer Diagnostics Market Key Players Head office and Area Served
3.4 Key Players Breast Cancer Diagnostics Market Product Solution and Service
3.5 Date of entering into Breast Cancer Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2027)
4.1 Global Breast Cancer Diagnostics Market Historic Market Size by Type (2015-2021)
4.2 Global Breast Cancer Diagnostics Market Forecasted Market Size by Type (2021-2027)
5 Breast Cancer Diagnostics Market Breakdown Data by Application (2015-2027)
5.1 Global Breast Cancer Diagnostics Market Size by Application (2015-2021)
5.2 Global Breast Cancer Diagnostics Market Forecasted Market Size by Application (2021-2027)
6 North America
6.1 North America Breast Cancer Diagnostics Market Size (2015-2021)
6.2 Breast Cancer Diagnostics Market Key Players in North America (2019-2021)
6.3 North America Breast Cancer Diagnostics Market Size by Type (2015-2021)
6.4 North America Breast Cancer Diagnostics Market Size by Application (2015-2021)
7 Europe
7.1 Europe Breast Cancer Diagnostics Market Size (2015-2021)
7.2 Breast Cancer Diagnostics Market Key Players in Europe (2019-2021)
7.3 Europe Breast Cancer Diagnostics Market Size by Type (2015-2021)
7.4 Europe Breast Cancer Diagnostics Market Size by Application (2015-2021)
8 China
8.1 China Breast Cancer Diagnostics Market Size (2015-2021)
8.2 Breast Cancer Diagnostics Market Key Players in China (2019-2021)
8.3 China Breast Cancer Diagnostics Market Size by Type (2015-2021)
8.4 China Breast Cancer Diagnostics Market Size by Application (2015-2021)
9 Japan
9.1 Japan Breast Cancer Diagnostics Market Size (2015-2021)
9.2 Breast Cancer Diagnostics Market Key Players in Japan (2019-2021)
9.3 Japan Breast Cancer Diagnostics Market Size by Type (2015-2021)
9.4 Japan Breast Cancer Diagnostics Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Breast Cancer Diagnostics Market Size (2015-2021)
10.2 Breast Cancer Diagnostics Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Breast Cancer Diagnostics Market Size by Type (2015-2021)
10.4 Southeast Asia Breast Cancer Diagnostics Market Size by Application (2015-2021)
11 India
11.1 India Breast Cancer Diagnostics Market Size (2015-2021)
11.2 Breast Cancer Diagnostics Market Key Players in India (2019-2021)
11.3 India Breast Cancer Diagnostics Market Size by Type (2015-2021)
11.4 India Breast Cancer Diagnostics Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Breast Cancer Diagnostics Market Size (2015-2021)
12.2 Breast Cancer Diagnostics Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Breast Cancer Diagnostics Market Size by Type (2015-2021)
12.4 Central & South America Breast Cancer Diagnostics Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Breast Cancer Diagnostics Market Introduction
13.4 Breast Cancer Diagnostics Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Breast Cancer Diagnostics Market Key Market Segments
Table 2. Key Players Covered: Ranking by Breast Cancer Diagnostics Market Revenue
Table 3. Ranking of Global Top Breast Cancer Diagnostics Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breast Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Breast Cancer Diagnostics Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Breast Cancer Diagnostics Market Players to Combat Covid-19 Impact
Table 10. Global Breast Cancer Diagnostics Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 11. Global Breast Cancer Diagnostics Market Size by Regions (US$ Million): 2021 VS 2027
Table 12. Global Breast Cancer Diagnostics Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Breast Cancer Diagnostics Market Share by Regions (2015-2021)
Table 14. Global Breast Cancer Diagnostics Market Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 15. Global Breast Cancer Diagnostics Market Share by Regions (2021-2027)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Breast Cancer Diagnostics Market Growth Strategy
Table 20. Main Points Interviewed from Key Breast Cancer Diagnostics Market Players
Table 21. Global Breast Cancer Diagnostics Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Breast Cancer Diagnostics Market Share by Players (2015-2021)
Table 23. Global Top Breast Cancer Diagnostics Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostics Market as of 2019)
Table 24. Global Breast Cancer Diagnostics Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Breast Cancer Diagnostics Market Product Solution and Service
Table 27. Date of entering into Breast Cancer Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 30. Global Breast Cancer Diagnostics Market Size Share by Type (2015-2021)
Table 31. Global Breast Cancer Diagnostics Market Revenue Market Share by Type (2021-2027)
Table 31. Global Breast Cancer Diagnostics Market Size Share by Application (2015-2021)
Table 33. Global Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 34. Global Breast Cancer Diagnostics Market Size Share by Application (2021-2027)
Table 35. North America Key Players Breast Cancer Diagnostics Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Breast Cancer Diagnostics Market Share (2019-2021)
Table 37. North America Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 38. North America Breast Cancer Diagnostics Market Share by Type (2015-2021)
Table 39. North America Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 40. North America Breast Cancer Diagnostics Market Share by Application (2015-2021)
Table 41. Europe Key Players Breast Cancer Diagnostics Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Breast Cancer Diagnostics Market Share (2019-2021)
Table 43. Europe Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Breast Cancer Diagnostics Market Share by Type (2015-2021)
Table 45. Europe Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Breast Cancer Diagnostics Market Share by Application (2015-2021)
Table 47. China Key Players Breast Cancer Diagnostics Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Breast Cancer Diagnostics Market Share (2019-2021)
Table 49. China Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 50. China Breast Cancer Diagnostics Market Share by Type (2015-2021)
Table 51. China Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 52. China Breast Cancer Diagnostics Market Share by Application (2015-2021)
Table 53. Japan Key Players Breast Cancer Diagnostics Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Breast Cancer Diagnostics Market Share (2019-2021)
Table 55. Japan Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Breast Cancer Diagnostics Market Share by Type (2015-2021)
Table 57. Japan Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Breast Cancer Diagnostics Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Breast Cancer Diagnostics Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Breast Cancer Diagnostics Market Share (2019-2021)
Table 61. Southeast Asia Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Breast Cancer Diagnostics Market Share by Type (2015-2021)
Table 63. Southeast Asia Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Breast Cancer Diagnostics Market Share by Application (2015-2021)
Table 65. India Key Players Breast Cancer Diagnostics Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Breast Cancer Diagnostics Market Share (2019-2021)
Table 67. India Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 68. India Breast Cancer Diagnostics Market Share by Type (2015-2021)
Table 69. India Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 70. India Breast Cancer Diagnostics Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Breast Cancer Diagnostics Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Breast Cancer Diagnostics Market Share (2019-2021)
Table 73. Central & South America Breast Cancer Diagnostics Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Breast Cancer Diagnostics Market Share by Type (2015-2021)
Table 75. Central & South America Breast Cancer Diagnostics Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Breast Cancer Diagnostics Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Breast Cancer Diagnostics Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Breast Cancer Diagnostics Market Share by Type: 2021 VS 2027
Figure 2. Global Breast Cancer Diagnostics Market Share by Application: 2021 VS 2027
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Breast Cancer Diagnostics Market Report Years Considered
Figure 8. Global Breast Cancer Diagnostics Market Size YoY Growth 2015-2027 (US$ Million)
Figure 9. Global Breast Cancer Diagnostics Market Share by Regions: 2021 VS 2027
Figure 10. Global Breast Cancer Diagnostics Market Share by Regions (2021-2027)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Breast Cancer Diagnostics Market Share by Players in 2019
Figure 13. Global Top Breast Cancer Diagnostics Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Breast Cancer Diagnostics Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Breast Cancer Diagnostics Market Revenue in 2019
Figure 15. North America Breast Cancer Diagnostics Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Breast Cancer Diagnostics Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Breast Cancer Diagnostics Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Breast Cancer Diagnostics Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Breast Cancer Diagnostics Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Breast Cancer Diagnostics Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Breast Cancer Diagnostics Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
